Lancet study: No statistically significant clinical benefits of remdesivir in COVID patients
from India | The Indian Express https://ift.tt/2VPsTDq
Crisis on LAC worst in decades, India response firm & mature: Shringla
from Front Page | The Indian Express https://ift.tt/2TDCfAf
Comments
Post a Comment